Zhihui Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhihui Yang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Juan Liu
Wuhan University
2 shared publications - Feng Yang
School of Computer Science, Wuhan University, Wuhan, 430072, Hubei, China
1 shared publication - Hayat Ali Shah
Institute of Artificial Intelligence, School of Computer Science, Wuhan University, Wuhan, P. R. China
1 shared publication - Jian Zhang
School of Computer Science, Wuhan University,Wuhan,China,430072
1 shared publication - Xiaolei Zhang
Department of Chemical and Process Engineering University of Strathclyde Glasgow UK
1 shared publication Xuekai Zhu
School of Computer Science, Wuhan University,Wuhan,China,430072
1 shared publication
Latest Publications
- 1 June 2024
- Published by World Scientific Pub Co Pte Ltd in Journal of Bioinformatics and Computational Biology
- Vol. 22 (03) , 2450010
Gtie-Rt: A comprehensive graph learning model for predicting drugs targeting metabolic pathways in human
Drugs often target specific metabolic pathways to produce a therapeutic effect. However, these pathways are complex and interconnected, making it challenging to predict a drug’s potential effects on an organism’s overall metabolism. The mapping of drugs with targeting metabolic pathways in the organisms can provide a more complete understanding of the metabolic effects of a drug and help to identify potential drug–drug interactions. In this study, we proposed a machine learning hybrid model Graph Transformer Integrated Encoder (GTIE-RT) for mapping drugs to target metabolic pathways in human. The proposed model is a composite of a Graph Convolution Network (GCN) and transformer encoder for graph embedding and attention mechanism. The output of the transformer encoder is then fed into the Extremely Randomized Trees Classifier to predict target metabolic pathways. The evaluation of the GTIE-RT on drugs dataset demonstrates excellent performance metrics, including accuracy (>95%), recall (>92%), precision (>93%) and F1-score (>92%). Compared to other variants and machine learning methods, GTIE-RT consistently shows more reliable results.
- 1 June 2024
- Published by World Scientific Pub Co Pte Ltd in Journal of Bioinformatics and Computational Biology
- Vol. 22 (03) , 2450010
Gtie-Rt: A comprehensive graph learning model for predicting drugs targeting metabolic pathways in human
Drugs often target specific metabolic pathways to produce a therapeutic effect. However, these pathways are complex and interconnected, making it challenging to predict a drug’s potential effects on an organism’s overall metabolism. The mapping of drugs with targeting metabolic pathways in the organisms can provide a more complete understanding of the metabolic effects of a drug and help to identify potential drug–drug interactions. In this study, we proposed a machine learning hybrid model Graph Transformer Integrated Encoder (GTIE-RT) for mapping drugs to target metabolic pathways in human. The proposed model is a composite of a Graph Convolution Network (GCN) and transformer encoder for graph embedding and attention mechanism. The output of the transformer encoder is then fed into the Extremely Randomized Trees Classifier to predict target metabolic pathways. The evaluation of the GTIE-RT on drugs dataset demonstrates excellent performance metrics, including accuracy (>95%), recall (>92%), precision (>93%) and F1-score (>92%). Compared to other variants and machine learning methods, GTIE-RT consistently shows more reliable results.
- Open Access
- 1 March 2023
- Published by Tsinghua University Press in Big Data Mining and Analytics
- Vol. 6 (1) , 1-10
FingerDTA: A Fingerprint-Embedding Framework for Drug-Target Binding Affinity Prediction
Many efforts have been exerted toward screening potential drugs for targets, and conducting wet experiments remains a laborious and time-consuming approach. Artificial intelligence methods, such as Convolutional Neural Network (CNN), are widely used to facilitate new drug discovery. Owing to the structural limitations of CNN, features extracted from this method are local patterns that lack global information. However, global information extracted from the whole sequence and local patterns extracted from the special domain can influence the drugtarget affinity. A fusion of global information and local patterns can construct neural network calculations closer to actual biological processes. This paper proposes a Fingerprint-embedding framework for Drug-Target binding Affinity prediction (FingerDTA), which uses CNN to extract local patterns and utilize fingerprints to characterize global information. These fingerprints are generated on the basis of the whole sequence of drugs or targets. Furthermore, FingerDTA achieves comparable performance on Davis and KIBA data sets. In the case study of screening potential drugs for the spike protein of the coronavirus disease 2019 (COVID-19), 7 of the top 10 drugs have been confirmed potential by literature. Ultimately, the docking experiment demonstrates that FingerDTA can find novel drug candidates for targets. All codes are available at http://lanproxy.biodwhu.cn:9099/mszjaas/FingerDTA.git.
- 1 March 2023
- Published by Tsinghua University Press in Big Data Mining and Analytics
- Vol. 6 (1) , 1-10
Open AccessFingerDTA: A Fingerprint-Embedding Framework for Drug-Target Binding Affinity Prediction
Many efforts have been exerted toward screening potential drugs for targets, and conducting wet experiments remains a laborious and time-consuming approach. Artificial intelligence methods, such as Convolutional Neural Network (CNN), are widely used to facilitate new drug discovery. Owing to the structural limitations of CNN, features extracted from this method are local patterns that lack global information. However, global information extracted from the whole sequence and local patterns extracted from the special domain can influence the drugtarget affinity. A fusion of global information and local patterns can construct neural network calculations closer to actual biological processes. This paper proposes a Fingerprint-embedding framework for Drug-Target binding Affinity prediction (FingerDTA), which uses CNN to extract local patterns and utilize fingerprints to characterize global information. These fingerprints are generated on the basis of the whole sequence of drugs or targets. Furthermore, FingerDTA achieves comparable performance on Davis and KIBA data sets. In the case study of screening potential drugs for the spike protein of the coronavirus disease 2019 (COVID-19), 7 of the top 10 drugs have been confirmed potential by literature. Ultimately, the docking experiment demonstrates that FingerDTA can find novel drug candidates for targets. All codes are available at http://lanproxy.biodwhu.cn:9099/mszjaas/FingerDTA.git.